Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-RISPERIDONE | 4.0MG | TABLET | Resolved | 2021-05-20 | 2021-07-09 | 139746 |
TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2021-05-20 | 2021-07-22 | 139749 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2021-05-20 | 2021-06-24 | 139752 |
TEVA-SILDENAFIL | 50MG | TABLET | Resolved | 2021-05-20 | 2021-08-05 | 139755 |
TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139758 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-05-27 | 2021-08-06 | 140033 |
AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-05-27 | 2021-08-06 | 140036 |
TEVA-DILTIAZEM CD | 240MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-05-27 | 2021-07-09 | 140039 |
TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-05-27 | 2021-07-09 | 140042 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-05-27 | 2021-08-06 | 140045 |
TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-06-03 | 2021-07-09 | 140360 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140363 |
RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2021-06-03 | 2021-07-09 | 140366 |
AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-06-03 | 2021-08-05 | 140369 |
TEVA-DILTIAZEM CD | 240MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-06-03 | 2021-06-10 | 140372 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140375 |
TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140378 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140381 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140384 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-06-03 | 2021-07-15 | 140387 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |